Additional file 1: of Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

Table S1. Ethic committee. (PPTX 81 kb)

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.6084/m9.figshare.c.3642146_d1
URL https://figshare.com/articles/Additional_file_1_of_Study_protocol_of_the_TRICOLORE_trial_a_randomized_phase_III_study_of_oxaliplatin-based_chemotherapy_versus_combination_chemotherapy_with_S-1_irinotecan_and_bevacizumab_as_first-line_therapy_for_metastatic_colorectal_cancer/4461428
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Komatsu, Yoshito
Author Ishioka, Chikashi
Author Shimada, Ken
Author Yamada, Yasuhide
Author Gamoh, Makio
Author Sato, Atsushi
Author Yamaguchi, Tatsuro
Author Yuki, Satoshi
Author Morita, Satoshi
Author Takahashi, Shin
Author Goto, Rei
Author Kurihara, Minoru
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From FigShare
Hosted By FigShare
Publication Date 2015-09-09
Additional Info
Field Value
Language English
Resource Type Conference object
system:type publication
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/publication?articleId=od______2073::9625b619ee4aa1c9a647e00b49fc0c77
Author jsonws_user
Last Updated 25 December 2020, 13:27 (CET)
Created 25 December 2020, 13:27 (CET)